Grantham, Mayo, Van Otterloo & Co (GMO)’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.7M | Sell |
352,695
-39,456
| -10% | -$4.77M | 0.13% | 81 |
|
|
2025
Q1 | $43.7M | Sell |
392,151
-185,750
| -32% | -$20.7M | 0.14% | 90 |
|
|
2024
Q4 | $56.2M | Sell |
577,901
-87,118
| -13% | -$8.48M | 0.18% | 54 |
|
|
2024
Q3 | $76.5M | Sell |
665,019
-114,662
| -15% | -$13.2M | 0.24% | 46 |
|
|
2024
Q2 | $83M | Sell |
779,681
-166,195
| -18% | -$17.7M | 0.28% | 47 |
|
|
2024
Q1 | $91.5M | Sell |
945,876
-581,499
| -38% | -$56.2M | 0.33% | 41 |
|
|
2023
Q4 | $154M | Sell |
1,527,375
-299,888
| -16% | -$30.3M | 0.68% | 34 |
|
|
2023
Q3 | $186M | Buy |
1,827,263
+1,144,307
| +168% | +$117M | 0.88% | 31 |
|
|
2023
Q2 | $68.9M | Buy |
682,956
+672,756
| +6,596% | +$67.9M | 0.32% | 56 |
|
|
2023
Q1 | $938K | Sell |
10,200
-34,800
| -77% | -$3.2M | ﹤0.01% | 495 |
|
|
2022
Q4 | $4.08M | Buy |
+45,000
| New | +$4.08M | 0.02% | 368 |
|
|
2022
Q2 | – | Sell |
-3,500
| Closed | -$307K | – | 788 |
|
|
2022
Q1 | $307K | Sell |
3,500
-192,200
| -98% | -$16.9M | ﹤0.01% | 638 |
|
|
2021
Q4 | $17.1M | Buy |
195,700
+32,800
| +20% | +$2.87M | 0.08% | 186 |
|
|
2021
Q3 | $13.3M | Buy |
162,900
+159,900
| +5,330% | +$13.1M | 0.07% | 214 |
|
|
2021
Q2 | $274K | Buy |
+3,000
| New | +$274K | ﹤0.01% | 671 |
|
|
2019
Q3 | – | Sell |
-4,500
| Closed | -$411K | – | 771 |
|
|
2019
Q2 | $411K | Sell |
4,500
-1,600
| -26% | -$211K | ﹤0.01% | 622 |
|
|
2019
Q1 | $586K | Sell |
6,100
-4,400
| -42% | -$423K | ﹤0.01% | 562 |
|
|
2018
Q4 | $901K | Sell |
10,500
-6,600
| -39% | -$566K | 0.01% | 359 |
|
|
2018
Q3 | $1.47M | Sell |
17,100
-2,400
| -12% | -$207K | 0.01% | 336 |
|
|
2018
Q2 | $1.47M | Buy |
+19,500
| New | +$1.47M | 0.01% | 321 |
|